The National Practice Guideline was developed for the treatment of opioid use disorder and the prevention of opioid overdose-related deaths
The National Practice Guideline for the Treatment of Opioid Use Disorder – 2020 Focused Update
The National Practice Guideline is intended to inform and empower clinicians, health system administrators, criminal justice system administrators, and policymakers who are interested in implementing evidence-based practices to improve outcomes for individuals with OUD. This is especially critical in the context of the ongoing COVID-19 emergency, which threatens to curtail patient access to evidence-based treatment. The document is an update to the previous NPG released in 2015 and includes major revisions to 35 existing recommendations, along with the addition of 13 new recommendations.
The focused update was developed over the course of 14 months with consensus from an independent committee of experts and the use of a rigorous RAND/UCLA Appropriateness Method (RAM) facilitated by researchers from Research Triangle Institute (RTI).
The Journal of Addiction Medicine features an executive summary on the National Practice Guideline that describes the rationale and process for creating this guideline, and summarizes the recommendations.
Official ASAM National Practice Guideline quick-reference tools provide healthcare providers with instant access to current guidelines in a clear concise format.
Multi-copy and group orders are available using the link above or call 407-878-7606 for more information.
This 5-part webinar series discusses the fundamentals of the guideline update, and topics specific to pregnant women, opioid use disorder and pain, individuals in the Criminal Justice System, and adolescents and young adults.
Tools, messages and banners to promote the guideline.